20
Glaxosmithkline Research & Development Limited London Gb, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Ceftazidime Pentahydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2004-306 - Rev 01
This Chemical Type CEP, issued on July 02, 2013, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1405 associated with this CEP further emphasizes